Hillel Ephros
Seton Hall University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hillel Ephros.
Journal of Oral and Maxillofacial Surgery | 1991
Hillel Ephros; Hee Young Lee
The modified Brosch procedure has been described. It represents a reasonable alternative to resection or marsupialization when treating large OKC that occupy the molar, angle, and ramus regions of the mandible. Extraction of teeth affected by the lesion as well as generous removal of partially eroded bone and overlying soft tissues may contribute to lower recurrence rates. Cryosurgical or mechanical treatment of the bony cavity, which is well visualized using this technique, may also lead to improved long-term results. Treatment must be followed by continued, careful observation of the patient.
Oral Surgery, Oral Medicine, Oral Pathology, and Oral Radiology | 2013
Matthew S. Epstein; Hillel Ephros; Joel B. Epstein
Bisphosphonates (BPs) were the first class of drugs commonly used to prevent skeletal-related events (SRE) in patients with osteoporosis, multiple myeloma (MM), or solid tumors with metastases to bone. A new alternative class of agents, receptor activator of nuclear factor kappa-B ligand (RANKL) inhibitors, are now available for use in these indications and have the potential to replace intravenous BPs. This paper presents a review of the current literature on denosumab and its association with osteonecrosis of the jaw (ONJ). Denosumab is a RANKL inhibitor that has recently been approved for the prevention of SRE for the same indications as BPs except for MM. Although the overall frequency of denosumab-related ONJ may be similar or higher than estimates of the occurrence rate of bisphosphonate-related ONJ, evidence continues to support appropriate planning and preventive care can reduce the likelihood of adverse effects, including osteonecrosis.
Oral and Maxillofacial Surgery Clinics of North America | 2010
Jennifer Lyne; Hillel Ephros; Scott Bolding
Adverse psychological outcomes are more prevalent among patients undergoing elective, appearance-altering surgery than are physical complications. Patients may experience depression, posttraumatic stress disorder, or an exacerbation of preexisting symptoms related to body dysmorphic disorder. Some have directed anger against themselves or against the operating surgeon with suicide, litigation, harassment, and homicide, all well documented. Although there are well-established protocols to conduct medical and anesthetic risk stratification, such protocols do not exist for psychological risk assessment (PRA). The literature related to this is reviewed, the need for PRA is discussed, and an approach to PRA for dentists and surgeons is proposed.
Indian Journal of Medical Research | 2010
Hillel Ephros; Mansoor Madani; Sumitra C. Yalamanchili
Journal of Oral and Maxillofacial Surgery | 2004
Bryan R Harvey; Hillel Ephros; Robert J. DeFalco
Atlas of the oral and maxillofacial surgery clinics of North America | 2007
Hillel Ephros; Mansoor Madani; Brett M. Geller; Robert J. DeFalco
Journal of Oral and Maxillofacial Surgery | 2004
Hillel Ephros
Oral and Maxillofacial Surgery Clinics of North America | 2010
Hillel Ephros
Journal of Oral and Maxillofacial Surgery | 2008
Hillel Ephros; Jennifer Lyne
Journal of the American Dental Association | 2002
Hillel Ephros